Page loading, please wait...
Antibiotics and antimicrobial therapy
Hello, guest! :: Today: Wednesday, October 16, 2019 Russian page Russian 
 Main page :: IAC :: ISPR :: SCMAR :: IACMAC :: CMAC
Site navigation


Clinical Microbiology and Antimicrobial Chemotherapy - Official IACMAC Journal
Conferences, Seminars and Workshops

IACMAC activity plan for 2018-2019

  • Eurasian Congress on Antimicrobial Therapy and Clinical Microbiology (October 17–18, 2019, Ufa)
  • Certification workshop of professional education on specialty “Bacteriology” (October 21 – November 22, 2019, Smolensk)

Online course “Antimicrobial Stewardship: Managing Antibiotic Resistance”

You are invited to participate in Massive Open Online Course (MOOC) in Russian. This educational course was developed by Dundee University, the British Society for Antimicrobial Chemotherapy (BSAC) and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC).

IACMAC Educational Program

The National educational program “Diagnostics, treatment and prevention of infectious diseases caused by multidrug resistant microorganisms”

Nosocomial infectious diseases (2 session)

  • 05.10.2019 — DoubleTree by Hilton Tyumen Hotel, 46, Ordzhonikidze, Tumen
  • 12.10.2019 — Vedensky Hotel, 37, Bolshoy prospekt Petrogradskaya storona, St. Petersburg

Community-acquired infectious diseases (3 session)

  • 05.10.2019 — “Onegin” business center, 49, Rozy Luksemburg str., Ekaterinburg
  • 12.10.2019 — Park Inn by Radisson Sochi City Centre, 56, Gorkogo str., Sochi

Dear Colleagues! Due to certain technical issues and obstacles the list of cities participating in the National educational program “Diagnostics, treatment and prevention of infectious diseases caused by multidrug resistant microorganisms. Nosocomial infectious diseases” was shortened.


Dear colleagues! We encourage to take part in multicenter prospective microbiological study of the antimicrobial resistance of community-acquired pathogens: S. pneumoniae, H. influenzae and S. pyogenes (PeGAS study).

Since 2015 IAC and IACMAC have conducted multicenter study aimed to evaluate the prevalence of mutation resistance to macrolide antibiotic in Mycoplasma pneumonia and Mycoplasma genitalium.

Website News

European Committee on Antimicrobial Susceptibility Testing (EUCAST) has amended the clinical classification of susceptibility (categories S,I and R): currently the clinical evaluation of susceptibility is connected with drug exposure in the nidus of infection.

The occupational standard on specialty "Medical microbiology" from the Ministry of Healthcare of the Russian Federation is posted on IACMAC website.

Clinical Microbiology and Antimicrobial Chemotherapy vol. 20, №3 is posted on the website.

Clinical guidelines on diagnostics and treatment of community-acquired pneumonia in adults.

The Russian Respiratory Society (RRC) and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) have published for discussion the clinical guidelines on diagnostics and treatment of community-acquired pneumonia in adults.

Clinical guidelines “Mucoviscidosis: microbiological diagnostics of chronic respiratory infection”

Clinical guidelines on antimicrobial susceptibility testing, approved at the IACMAC extended session in Moscow are posted on the website.

Clinical guidelines on isolation, identification and antimicrobial susceptibility of Helicobacter pylori are added.

New Articles
Site News

Merck’s 15-valent pneumococcal vaccine noninferior to PCV13

Merck announced that its investigational 15-valent pneumococcal conjugate vaccine, or V114, was noninferior in protecting against the serotypes included in Pfizer’s 13-valent vaccine in children aged 6 to 12 weeks. V114 also produced an immune response in infants for two additional serotypes that cause disease — 22F and 33F.
Jul 24, 2019 - 10:20
Read more... :: Reads: 86
Site News

Necrotizing Infections Rise With Warming Oceans, Study Shows

As ocean temperatures increase, serious Vibrio vulnificus infections are on the rise in previously nonendemic areas, according to a case series published online in Annals of Internal Medicine.
Jul 23, 2019 - 09:40
Read more... :: Reads: 82
Site News

S. aureus prevalent on cell phones of nursing students

Staphylococcus aureus was present on 40% of sampled cell phones of university students, mostly belonging to nursing students, according to findings presented at ASM Microbe.
Jul 22, 2019 - 10:15
Read more... :: Reads: 82
Site News

FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumonia

The U.S. Food and Drug Administration today approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years and older. The FDA initially approved Zerbaxa in 2014 to treat complicated intra-abdominal infections and for complicated urinary tract infections.
Jun 13, 2019 - 11:20
Read more... :: Reads: 494
Site News

Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis

To compare the risk of serious infection associated with biologic and nonbiologic systemic medications in patients with psoriasis.
Jun 03, 2019 - 10:05
Read more... :: Reads: 609
Site News

Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria

This study uses in vitro assays and a mouse model to investigate antibacterial properties of ticagrelor to follow up findings from 2 clinical trials that showed patients taking ticagrelor for cardiovascular disease had a lower risk of infection-related death and improved lung function compared with patients treated with clopidogrel.
Jun 01, 2019 - 10:10
Read more... :: Reads: 622
Site News

Prophylactic antibiotics for the prevention of infection following operative vaginal delivery (ANODE): study protocol for a randomised controlled trial

Risk factors for maternal infection are clearly recognised, including caesarean section and operative vaginal birth. Antibiotic prophylaxis at caesarean section is widely recommended because there is clear systematic review evidence that it reduces incidence of maternal infection. Current WHO guidelines do not recommend routine antibiotic prophylaxis for women undergoing operative vaginal birth because of insufficient evidence of effectiveness. We aimed to investigate whether antibiotic prophylaxis prevented maternal infection after operative vaginal birth.
May 31, 2019 - 11:05
Read more... :: Reads: 633
Site News

Once-Daily Plazomicin for Complicated Urinary Tract Infections

The increasing multidrug resistance among gram-negative uropathogens necessitates new treatments for serious infections. Plazomicin is an aminoglycoside with bactericidal activity against multidrug-resistant (including carbapenem-resistant) Enterobacteriaceae.
May 30, 2019 - 10:15
Read more... :: Reads: 627
Site News

Osteoarticular manifestations of human brucellosis: A review

Brucellosis is a common global zoonotic disease, which is responsible for a range of clinical manifestations. Fever, sweating and musculoskeletal pains are observed in most patients. The most frequent complication of brucellosis is osteoarticular involvement, with 10% to 85% of patients affected.
May 29, 2019 - 12:15
Read more... :: Reads: 619
Site News

Effectiveness of honey dressing in the treatment of diabetic foot ulcers: A systematic review and meta-analysis

Honey dressing has been applied in the treatment of diabetic foot ulcers (DFUs). However, there is a lack of research showing ample evidence that honey dressing is more effective in the treatment of DFUs than other dressings. This study aimed to examine the effects of honey dressing on wound-healing process for DFUs.
Mar 20, 2019 - 10:15
Read more... :: Reads: 793
Next »

Institute of Antimicrobial Chemotherapy (IAC) Scientific Center of Monitoring Antimicrobial Resistance The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy Department of Clinical Pharmacology
© 2000-2019 IAC SSMA